Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines

British Journal of Cancer

Volumn 76, Issue 7, 1997, Pages 884-889

  Kawa, S ^a   Nikaido, T ^a   Aoki, Y ^a   Zhai, Y ^a   Kumagai, T ^a   Furihata, K ^a   Fujii, S ^a   Kiyosawa, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

22 oxa calcitriol; p21; p27; Pancreatic cancer; Vitamin D

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; PROTEIN P21; VITAMIN D DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0030752754     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.479     Document Type: Article

References (34)

1. 3. Proc Natl Acad Sci USA 78: 4990-4994
2. 3 with oxygen atom in the side chain skeleton. FEBS Lett 226: 58-62.
3. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinolgy 129: 832-837
4. Abe-Hashimoto J, Kikuchi T, Matsumoto T, Nishii Y, Ogata E and Ikeda K (1993) Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res 53: 2534-2537
5. Anzano MA, Smith JM, Ukovic MR, Peer CW, Mullen LT, Lettero JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL, Brown CC, Roberts AH and Sporn MB (1944) 1α,25-dihydroxy-16-enc-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res 54: 1653-1656
6. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CI, Hrunan RH, Yeo CJ and Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8: 27-32
7. 3. Cancer Res 47: 21-25
8. El-Deiry W, Tokino T, Veleulescu V, Levy D, Parsons R, Trent J, Lin D, Mercer E, Kinzler K and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
9. 3 metabolites. Cancer Res 43: 4443-4447
10. Gu Y, Turck CW and Morgan DO (1993) Inhibition of Cdk2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710
11. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D and Lassar AB (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021
12. 1 cyclin-dependent kinases. Cell 75: 805-816
13. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80: 201-204
14. Jiang H, Lin J, Su ZZ, Collart FR, Huberman L and Fisher PB (1994) Induction of differentiation in human promyclocytic HL-60 leukemia cells activates p21, WAF1/CIP1. expression in the absence of p53. Oncogene 9: 3397-3406
15. 3 on the proliferation of pancreatic cancer cell lines. Gastroenterology 110: 1605-1613
16. 3 is linked to dephosphorylation of retinoblastoma gene product. Biochem Biophys Res Commun 196: 487-493
17. 3 analogues. Chem Pharmacol Bull 34: 2286-2289
18. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142-153
19. 3 analogues. Chem Pharmacol Bull 34: 4410-4413
20. Pardce AB (1974) A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71: 1286-1290
21. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW and Elledge SJ (1995) p53-Independent expression of p21/Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027
22. 3 on primary cultures of human prostatic cells. Cancer Res 54: 805-810
23. Peter M and Herskowitz I (1994) Joining the complex: Cyclin-dependent kinase inhibitory proteins and cell cycle. Cell 79: 181-184
24. Peters G (1994) Stifled by inhibitors. Nature 371: 204-205
25. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague JM, Roberts J and Koff A (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22
26. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk-4. Nature 366: 704-707
27. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 53: 3712-3718
28. 1-dependent kinase. Science 267: 1022-1024
29. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and el Houseini ME (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396
30. Villa MR, Lioreta J, Schussler MH, Berrozpe G, Welt S and Real FX (1995) New pancreatic cancer cell lines that represent distinct stages of ductal differentiation. Lab Invest 72: 395-404
31. 3, inhibits azoxymethane-induced colonic tumorigenesis. Cancer Res 55: 3050-3054
32. 3 in HL60 cells. Cancer Res 56: 264-267
33. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R and Beach D (1993 p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704
34. Zhang W, Grasso L, McClain CD, Gambel AM, Salvatore T, Deisseroth AB and Mercer WD (1995) p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest according monocyte/macrophage differentiation. Cancer Res 55: 668-674